a quick scan of the article suggests that the valve in question was jammed in surgically without suturing. This led to the confusion on the part of our osmotic friend about sutureless valve versus sutured valve. If you take DuAVR off the catheter, I guess this could be another clinical trial for SAVR.
- Forums
- ASX - By Stock
- Anteris Channel 9 Interview 2022
AVR
anteris technologies global corp.
Add to My Watchlist
0.00%
!
$5.91

a quick scan of the article suggests that the valve in question...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.91 |
Change
0.000(0.00%) |
Mkt cap ! $91.59M |
Open | High | Low | Value | Volume |
$5.93 | $5.95 | $5.91 | $3.261K | 551 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 400 | $5.90 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.00 | 1000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 2103 | 5.860 |
1 | 170 | 5.850 |
1 | 857 | 5.830 |
1 | 900 | 5.780 |
1 | 3000 | 5.620 |
Price($) | Vol. | No. |
---|---|---|
6.000 | 1000 | 1 |
6.070 | 43 | 1 |
6.080 | 260 | 1 |
6.180 | 50 | 1 |
6.400 | 130 | 1 |
Last trade - 10.35am 27/06/2025 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online